The Akkermansia Company Introduces Innovative Gut Health Supplement to the U.S. Market"
PorAinvest
jueves, 27 de junio de 2024, 11:16 am ET1 min de lectura
AMZN--
The Akkermansia Company, a pioneering firm in gut health research, has made waves in the U.S. market with the launch of its first consumer product, Healthy Weight [1]. This innovative supplement combines the company's proprietary pasteurized Akkermansia muciniphila MucT™ with EGCG green tea and chromium, all proven to support weight management and overall wellness.
Akkermansia, a bacterium linked to improved gut health, had gained significant attention in recent years due to its potential benefits in addressing various health conditions [2]. In the absence of Akkermansia in the gut, weight management can become a challenge. A review by a functional medicine nutritionist shared on Metagenics revealed that a patient's weight began to decrease significantly after incorporating an Akkermansia supplement into their diet [1].
The Akkermansia Company's inventors, Cani et al., have been awarded the first US patent related to treating metabolic disorders, including obesity, through the oral administration of Akkermansia [2]. Their patent victory paves the way for the company's introduction of Healthy Weight with Glucose Control, which aims to aid in weight management and promote healthy glucose metabolism.
Healthy Weight with Glucose Control is now available through Amazon, priced at $59.99 per 30-day supply [1]. The supplement's combination of proven ingredients offers a promising solution for individuals seeking to improve their gut health and manage their weight.
References:
[1] https://www.metagenics.com/akkermansia
[2] https://www.nutritioninsight.com/news/the-akkermansia-company-pioneers-probiotic-obesity-treatment-with-us-patent-win.html
FUSB--
MGNX--
The Akkermansia Company, pioneers in gut health, has launched its first U.S. consumer product, Healthy Weight, containing Akkermansia muciniphila, a bacterium linked to improved gut health and overall wellness. The company's proprietary pasteurized Akkermansia muciniphila MucT™, proven safe and effective in human trials, is combined with EGCG Green Tea and Chromium to aid in weight management. Healthy Weight has been available in Europe since 2021 and is now available in the U.S. through Amazon for $59.99 per 30-day supply.
The Akkermansia Company, a pioneering firm in gut health research, has made waves in the U.S. market with the launch of its first consumer product, Healthy Weight [1]. This innovative supplement combines the company's proprietary pasteurized Akkermansia muciniphila MucT™ with EGCG green tea and chromium, all proven to support weight management and overall wellness.
Akkermansia, a bacterium linked to improved gut health, had gained significant attention in recent years due to its potential benefits in addressing various health conditions [2]. In the absence of Akkermansia in the gut, weight management can become a challenge. A review by a functional medicine nutritionist shared on Metagenics revealed that a patient's weight began to decrease significantly after incorporating an Akkermansia supplement into their diet [1].
The Akkermansia Company's inventors, Cani et al., have been awarded the first US patent related to treating metabolic disorders, including obesity, through the oral administration of Akkermansia [2]. Their patent victory paves the way for the company's introduction of Healthy Weight with Glucose Control, which aims to aid in weight management and promote healthy glucose metabolism.
Healthy Weight with Glucose Control is now available through Amazon, priced at $59.99 per 30-day supply [1]. The supplement's combination of proven ingredients offers a promising solution for individuals seeking to improve their gut health and manage their weight.
References:
[1] https://www.metagenics.com/akkermansia
[2] https://www.nutritioninsight.com/news/the-akkermansia-company-pioneers-probiotic-obesity-treatment-with-us-patent-win.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios